Old Web
English
Sign In
Acemap
>
authorDetail
>
Julien Dagher
Julien Dagher
Centre national de la recherche scientifique
Pathology
Medicine
Clinical trial
ALK inhibitor
Crizotinib
2
Papers
146
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Wild-type VHL Clear Cell Renal Cell Carcinomas Are a Distinct Clinical and Histologic Entity: A 10-Year Follow-up
2016
European urology focus
Julien Dagher
Solène-Florence Kammerer-Jacquet
Angélique Brunot
Adélaïde Pladys
Jean-Jacques Patard
Karim Bensalah
Christophe Perrin
Gregory Verhoest
Jean Mosser
Alexandra Lespagnol
Cécile Vigneau
Frédéric Dugay
Marc Antoine Belaud-Rotureau
Nathalie Rioux-Leclercq
Show All
Source
Cite
Save
Citations (16)
Parallel FISH and immunohistochemical studies of ALK status in 3244 non-small-cell lung cancers reveal major discordances.
2014
Journal of Thoracic Oncology
Florian Cabillic
Audrey Gros
Frédéric Dugay
Hugues Begueret
Laura Mesturoux
Dan Cristian-Chiforeanu
Leïla Dufrenot
Vincent Jauffret
Dominique Dachary
R. Corre
Alexandra Lespagnol
Gwendoline Soler
Julien Dagher
Véronique Catros
Michèle Le Calve
Jean-Philippe Merlio
Marc Antoine Belaud-Rotureau
Show All
Source
Cite
Save
Citations (130)
1